Member Info for MIKODX

JohnHenry - They have a covid-19 antibody lateral flow test, as well as a CD4 HIV test, and a Food Intolerance self test product.

Gazza4563 - All you have to do is click on my profile and you will see I sent out that link this morning.
Wow you really are thick.

Fourfiguresbull - The fact that I bought back in means that my views were fair, constructive, informative, and as honest as possible. If I was ramping and deramping then I would have sold and not bought back in wouldn't I, you plank.

DJ79 - it 63 euros, so same price.

Contemplating whether to top up before it hits 60. I'm already looking at healthy profits and don't want to spoil it by buying in at these prices only for it to drop back and shrink my profits. At the same time, we might not see 50 for a long time. These are the tough decisions us investors have to make but at these prices, and with big companies now turning to renewable energy, it's beginning to look like low risk high rewards.

Seems like GDR has the same problem as ODX, nice products but no sales, although ODX does have at least a UK contract for its product. Sounds like this company does a lot of ramping up with no actual sales. Why doesn't GDR have any meaningful orders, and with the UK Govt crying out for rapid tests why isn't this product top of the list?

I'm thinking of buying in here but not sure this company has what it takes to deliver.

I mentioned this first thing this morning, your a bit late,
and yes it looks like the second UK govt order.

Fourfiguresbull - How can you blame the CEO if you lose money here? You lose money by making wrong decisions like buying too high, or selling too soon or too late. There has been ample opportunity for everyone here to make money. If you get it right you make money, if you get it wrong you lose, simple. The CEO is not responsible for that.

You can't tell people to stay in or get out of a stock, that is entirely up to them. Nothing is guaranteed with S&S. It may go up, it may tank, that's the risk you take. Suppose later on today we get an RNS for the second order, then Wednesday we get another RNS that Mologic test has been approved and we have orders? Then we are back over £1 again. That's how it works. Nothing is guaranteed.

Under the circumstances ODX is holding up very well.

33 Billion wiped off the stock market this morning, due to uncertainty over Brexit, and travel bans due to new Covid variant.

Everyone know's the lateral flow tests are not as accurate as the PCR tests, and never will be. But you have to have some sort of test that is quick and efficient. The speed at which the virus spreads you cannot rely on PCR tests. The govt has a contract with Abingdon Health to supply all their Antibody tests. ODX is in partnership with Abingdon Health so nothing has changed.

The antibody tests are used for surveillance so naturally they will be studying the data which takes longer than the antigen tests. The next order will be here soon and maybe orders from abroad, just relax.

Why did I buy back in after selling all my holdings?

Simple, orders are incoming are that's why.

https://bidstats.uk/tenders/?q=abingdon+health#741408767-740688122-19

Just bought in again. 49p paid.

Gla.

What a great week for AFC.
AFC has got my Portfolio looking in great shape,
look forward to next week.

I multibagged with SNG back in July and also TILS back in April both are great companies. I was also contemplating whether to buy back into SNG when they dropped back to 90p. But I chose TILS simply because they have a lot more going on as well as having the Covid inhaler, and also because they will be trading on the main market next year. I'm sure both will do well but I think TILS is really going to take off from here, fingers crossed.

Always good to see insiders investing in their own companies, shows they have confidence in their company.

Well done Nigel.

An update for the Inhaler and Foralumab which is being used to treat Covid patients in Brazil, is due anytime now. This will fly if the news is good.

Let's get this in perspective. Morses Club is unique in that it offers a face to face lending and collection service. Obviously with lockdown in March because of the Covid this greatly impacted the business. But within just three weeks of lockdown the company were able to recommence lending to existing HCC customers remotely.

By July, they had developed a platform which enabled them to restart lending remotely to new HCC customers. The customer response to the new cashless lending and remote collections model has been extremely positive and the new customer portal had over 117,000 new customers as at August 2020 and this has since risen to over 124,000. Obviously the business would have been impacted between March and July with the company unable to take on new customers until the remote platform was up and running in July.

In August 2020, the Group recommenced revised face-to-face lending and collection activity in customer homes, in strict accordance with government social distancing guidelines. Remote lending represented 58% of HCC loans issued in the six months to August 2020, rising to 61% in November 2020, demonstrating that a greater number of customers are choosing to utilise Morses Club's remote lending product.

The company are in a great space now and are continuing to strengthen with their new online platform. Now that adjustments have been made due to the Covid, we will now see real growth towards the end of Q4 through into the new year.

A positve RNS if you look at the bigger picture.

Dibs61 - With all respect I am aware that the SNG product is administered directly through the mouth, but TILS product does exactly the same thing using the TZLS-501 Anti-IL6R inhaler. TILS are at an advantage because they have reformulated the antibodies so that it can also be delivered nasally, or orally using the drug Foralumab.